In addition, results from the Danish National Birth Cohort (DNBC) [22] were also in disagreement with independently conducted work, with approximately 10% using APAP during the first 18 months of life [23] versus 65% using it within a 3-month period in an independent study evaluating a subset of the population assessed by the DNBC [24]
Common Side Effects When side effects occurred, they were typically mild, transient, and similar in frequency to placebo groups: Reported Adverse Effects Most Common (occurring in small percentage of participants): Mild to moderate headaches (most frequently reported, often resolving with continued use) Injection site reactions (minor redness, swelling, or irritation at injection site) Gastrointestinal effects (particularly at higher oral doses: mild nausea, diarrhea, flatulence) Fatigue (reported occasionally during initial adaptation period) Rare Events: One case of chest tightness was deemed possibly related to treatment in safety trials
They may also enhance how well other ingredients in the formula perform, which adds to the overall effect
Initiation of periodontal disease by bacteria is well-documented, and the end result, destruction of the alveolar bone and other connective tissues is readily observed
